Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
M&A
Technology & AI
Healthcare
M&A
Consumer & Retail
Energy
Media & Entertainment
Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!
M&A
Ishan M.
-
February 19, 2026
It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong fiscal third quarter, the company is leaning hard into its Agentforce...
Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?
M&A
Ishan Majumdar
-
February 10, 2026
Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline add-on in a year already defined by growth and scale. On...
Is Apple Outflanking Meta With This Q.AI Move?
M&A
Ishan Majumdar
-
January 31, 2026
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 20, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
APi Group CertaSite Acquisition Sparks Investor Debate
Industrials
Ishan Majumdar
-
December 11, 2025
In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...
Netflix Warner Bros Acquisition Could Change Streaming Forever
M&A
Ishan Majumdar
-
December 5, 2025
The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...
Paramount Warner Bros Merger vs. Netflix Explained!
M&A
Ishan Majumdar
-
December 4, 2025
The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...
Load more
Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!
M&A
Ishan M.
-
February 19, 2026
It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong fiscal third quarter, the company is...
Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?
M&A
Ishan Majumdar
-
February 16, 2026
Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline add-on in a year already defined...
Is Apple Outflanking Meta With This Q.AI Move?
M&A
Ishan Majumdar
-
February 16, 2026
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
February 6, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 23, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
APi Group CertaSite Acquisition Sparks Investor Debate
Industrials
Ishan Majumdar
-
December 19, 2025
In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...
Netflix Warner Bros Acquisition Could Change Streaming Forever
M&A
Ishan Majumdar
-
December 19, 2025
The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...
Paramount Warner Bros Merger vs. Netflix Explained!
M&A
Ishan Majumdar
-
December 19, 2025
The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...
Abbott Exact Sciences Acquisition: $21B Cancer Gamble
M&A
Ishan Majumdar
-
December 19, 2025
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...
Adobe Acquires Semrush: Game-Changer for Marketers?
M&A
Ishan Majumdar
-
December 19, 2025
Adobe just made a bold move that could shift the digital marketing landscape—again. Last week, the company announced a...
Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!
Healthcare
Ishan Majumdar
-
December 19, 2025
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...
Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda
Healthcare
Ishan Majumdar
-
December 19, 2025
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...
Load more